COTQF (Cotinga Pharmaceuticals) EV-to-EBITDA : -0.21 (As of Sep. 24, 2024)

Cotinga Pharmaceuticals EV-to-EBITDA Chart

Cotinga Pharmaceuticals Annual Data
	Trend	Apr10	Apr11	Apr12	Apr13	Apr14	Apr15	Apr16	Apr17	Apr18	Apr19
EV-to-EBITDA		Get a 7-Day Free Trial					-8.41	-13.85	-9.18	-1.34	-0.80

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
EV-to-EBITDA	Get a 7-Day Free Trial															-0.91	-0.80	-1.69	-1.59	-1.03

Competitive Comparison of Cotinga Pharmaceuticals's EV-to-EBITDA

For the Biotechnology subindustry, Cotinga Pharmaceuticals's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cotinga Pharmaceuticals's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cotinga Pharmaceuticals's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Cotinga Pharmaceuticals's EV-to-EBITDA falls into.

Cotinga Pharmaceuticals EV-to-EBITDA Calculation

Cotinga Pharmaceuticals's EV-to-EBITDA for today is calculated as:

Cotinga Pharmaceuticals's current Enterprise Value is $0.33 Mil.
Cotinga Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Jan. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cotinga Pharmaceuticals  (OTCPK:COTQF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Cotinga Pharmaceuticals's PE Ratio for today is calculated as:

Cotinga Pharmaceuticals's share price for today is $0.0001.
Cotinga Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jan. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.075.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Cotinga Pharmaceuticals EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals Business Description